Company / Cash per Share
Whitehawk Therapeutics, Inc. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.52
FY2025
5-year range
$1.17 / $58.60
FY2021-FY2025
Trend
+30.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $1.52.
Based on SEC 10-K filings.
1.52 in FY2025 with a 5-year CAGR of +7.7%.
Declined from $2.57 to $1.52 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -54.0%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 30.4% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.52 | +30.4% |
| FY2024 | $1.17 | -54.6% |
| FY2023 | $2.57 | -83.5% |
| FY2022 | $15.61 | -73.4% |
| FY2021 | $58.60 | +5482.8% |
| FY2020 | $1.05 | +10.6% |
| FY2019 | $0.95 | +26.8% |
| FY2018 | $0.75 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026